Social media has far more intrusive information than genomic data, genetic justice expert says

SiBionics announced today that it unveiled its GS3 continuous glucose monitor (CGM), which now has CE mark approval.

Enable Injections announced today that it received CE mark approval for its EnFuse syringe transfer system for drug delivery.

A consortium of Austrian research groups from the University of Vienna, MedUni Vienna and Technikum Wien, together with company partner DOC Medikus GmbH, has developed an innovative bioanalytical test system for radiopharmaceutical drug candidates for cancer diagnosis and therapy.

SCOTTSDALE, Ariz., March 20, 2025 /PRNewswire/ — Anuncia Medical, Inc. (“Anuncia”), a pioneering company in CSF management and neurocritical care, has received Breakthrough Device Designation from the FDA for its ReFlow® EVD, an innovative solution for external ventricular drains (EVDs) used to manage brain swelling and elevated intracranial pressure.

Sibel Health announced today that it closed a $30 million equity financing and earned its seventh FDA 510(k) clearance.

GE HealthCare (Nasdaq: GEHC) announced today that it launched its Invenia automated breast ultrasound (ABUS) premium offering.

Blood glucose is usually measured using invasive methods involving pricking small needles into the skin. But people suffering from diabetes have to test their glucose levels many times a day. This repeated use of needles is inconvenient and can increase the risk of potential infections.